CHMP recommends EU approval of Roche’s Xofluza® (baloxavir marboxil) for the treatment of influenza
One-dose, oral Xofluza has been recommended for approval for the treatment of uncomplicated influenza in…
One-dose, oral Xofluza has been recommended for approval for the treatment of uncomplicated influenza in…
Verana Health analysis of American Academy of Ophthalmology IRIS® Registry presented in a late-breaking oral…
TORONTO, Nov. 13, 2020 (GLOBE NEWSWIRE) — Braingrid Limited (CSE: BGRD) (“Braingrid” or the “Company”),…
VASCEPA®, compared with placebo, significantly reduced primary composite first and total major adverse cardiovascular events…
Pooled data analyses from Phase III ORION-9, -10 and -11 showed that inclisiran consistently reduced…
SAN DIEGO, Nov. 13, 2020 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology…
NEW YORK, NY, REHOVAT, ISRAEL, SINGAPORE, Nov. 13, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical…
AUSTIN, Texas, Nov. 13, 2020 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA) (the “Company”…
CARB-X and Cystic Fibrosis Foundation grants provide significant additional funding to advance CF-370 for Pseudomonas…
NEW YORK, Nov. 13, 2020 (GLOBE NEWSWIRE) — via NetworkNewsAudio – Cybin Inc. (NEO: CYBN) announces…
– Results from analysis of three Phase 3 clinical studies showed statistically significant improvement in…
Additional data from SIGNAL Huntington’s disease (HD) trial support continued development in HD and in…
– PEDFIC 1 meets both U.S. and EU primary and secondary endpoints with highly statistically…
–Single and multiple intravitreal injections of NGM621 appeared safe and well tolerated in first-in-human study,…
– Findings support upcoming launch of T-Detect™ COVID, first T-cell test for novel coronavirus– Data…
Phesgo offers faster and less invasive delivery of standard of care treatment with Perjeta and…
First report of pathological role for microglial calcium activity in cortical spreading depolarization (CSD), a…
– Data show longer-term, differentiated safety profile of vebicorvir and the importance of HBV pregenomic…
U.S. Food and Drug Administration (FDA) clearance of PMV Pharmaceutical’s investigational new drug application for…
SOUTH SAN FRANCISCO, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ:…